Graff, Gavin R <br/><br/>
Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.  [electronic resource] 

 -  Clinical drug investigation  2010 
 - 351-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1173-2563 
<br/><br/><label>Standard No.: </label>10.2165/11533390-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Capsules<br/>Child, Preschool<br/>Cystic Fibrosis--complications<br/>Delayed-Action Preparations<br/>Enzyme Replacement Therapy--methods<br/>Exocrine Pancreatic Insufficiency--drug therapy<br/>Female<br/>Gastrointestinal Agents--administration & dosage<br/>Humans<br/>Infant<br/>Male<br/>Pancrelipase--administration & dosage